Nanomaterials like liposomes and polymeric nanoparticles can be used to deliver drugs directly to the heart tissue, improving the efficacy and reducing the side effects of conventional medications. These nanocarriers can be designed to release their payload in a controlled manner, ensuring sustained therapeutic levels in the affected area.
